Skip to main content
. 2016 Aug 30;2016:5623089. doi: 10.1155/2016/5623089

Figure 6.

Figure 6

250 patients were studied for BRCA mutations by Access Array Fluidigm combined with 454 pyrosequencing and AGSA analysis. This sequencing methodology was compared to Sanger analysis in terms of percentage of amplicons to be reanalysed for BRCA1 (a) and BRCA2 (b), cost per patient (c), and time required to analyse 96 patients (d).